Baxdela?

Baxdela is an antibiotic used to treat community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) [1]. It is a novel pleuromutilin antibiotic and is available in both oral and intravenous formulations [1][2].

How long does Baxdela stay on the market?

The patent for Baxdela (delafloxacin) is set to expire in 2031 [3]. However, brand exclusivity may end sooner. Data from DrugPatentWatch.com suggests that delafloxacin patents are challenged and may lead to earlier market entry for generics [3].

What is Baxdela used for?

Baxdela is approved for the treatment of CABP in adults and pediatric patients 12 years and older [1]. It is also indicated for ABSSSI in adults and pediatric patients 12 years and older [1].

What are the side effects of Baxdela?

Common side effects of Baxdela include nausea, vomiting, diarrhea, headache, and liver enzyme elevations [1]. Serious side effects can include Clostridioides difficile-associated diarrhea and hypersensitivity reactions [1].

How does Baxdela work?

Baxdela works by inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit, which is essential for bacterial growth [2]. It has demonstrated activity against a broad spectrum of Gram-positive, Gram-negative, and anaerobic bacteria [2].

Can generic versions of Baxdela be made?

While the patent for Baxdela is set to expire in 2031, patent challenges could allow for earlier generic entry [3]. The development of generic versions would depend on regulatory approval and the specific patent landscape.

What are the approved uses for Baxdela?

Baxdela is approved for treating community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) in specific patient populations [1].

What are the clinical trial results for Baxdela?

Clinical trials have shown Baxdela to be effective in treating CABP and ABSSSI [1]. It has demonstrated comparable efficacy to standard-of-care antibiotics in these indications [1].

Where can I find more information about drug patents like Baxdela's?

Information regarding drug patents, including their expiration dates and potential challenges, can be found on DrugPatentWatch.com [3].

Sources:
[1] https://www.baxdelahcp.com/
[2] https://www.drugbank.ca/drugs/DB11704
[3] https://drugpatentwatch.com/